ABCL insider transaction filings
AbCellera Biologics Inc. — 47 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-24. Screen ABCL transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 7 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 4 filings by 3 insiders — 147,200 shares, $1,545,680 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: purchase of 53,613 shares @ $10.64 ($570,442) by Hayden Michael R, filed 2026-08-24.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Hayden Michael R — Director | 3 | 2 legs · 100,000 sh · $1,051,476 | — | 1 |
| Booth Andrew — Chief Financial Officer | 1 | 1 leg · 37,200 sh · $383,904 | — | — |
| Montalbano John S. — Director | 1 | 1 leg · 10,000 sh · $110,300 | — | — |
| Sandor Victor — Director | 1 | — | — | 1 |
| Seely Lynn — Director | 1 | — | — | 1 |
Recent Form 4 filings — AbCellera Biologics Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | Hayden Michael R — Director | Purchase (P): 53,613 @ $10.64 | EDGAR |
| 2026-08-18 | 4 | Montalbano John S. — Director | Purchase (P): 10,000 @ $11.03 | EDGAR |
| 2026-08-14 | 4 | Booth Andrew — Chief Financial Officer | Purchase (P): 37,200 @ $10.32 | EDGAR |
| 2026-08-14 | 4 | Hayden Michael R — Director | Purchase (P): 46,387 @ $10.37 | EDGAR |
| 2026-08-13 | 4 | Hayden Michael R — Director | Gift (G): 50,000 @ $0 | EDGAR |
| 2026-07-06 | 4 | Sandor Victor — Director | Grant/award (A): 152,207 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Seely Lynn — Director | Grant/award (A): 152,207 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Montalbano John S. — Director | Grant/award (A): 111,701 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Quake Stephen — Director | Grant/award (A): 111,701 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Hayden Michael R — Director | Grant/award (A): 111,701 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Booth Andrew — Chief Financial Officer | Option exercise (M): 250,000 @ $0.19 · Option exercise (M): 250,000 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Montalbano John S. — Director | Purchase (P): 20,000 @ $4.77 | EDGAR |
| 2026-03-02 | 4 | Thermopylae Holdings Ltd. — 10% owner | Purchase (P): 38,000 @ $3.44 | EDGAR |
| 2026-02-27 | 4 | Thermopylae Holdings Ltd. — 10% owner | Purchase (P): 177,457 @ $3.27 | EDGAR |
| 2026-02-27 | 4 | Booth Andrew — Chief Financial Officer | Purchase (P): 42,600 @ $3.42 | EDGAR |
| 2026-01-05 | 4 | Stimart Tryn — Chief Legal Officer | Grant/award (A): 539,265 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Lecault Veronique — Chief Technology Officer, Director | Grant/award (A): 539,265 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 2,106,505 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Booth Andrew — Chief Financial Officer | Grant/award (A): 808,898 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Thermopylae Holdings Ltd. — 10% owner | Gift (G): 225,000 @ $0 | EDGAR |
| 2025-12-19 | 4 | Quake Stephen — Director | Grant/award (A): 194,932 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | Montalbano John S. — Director | Purchase (P): 50,000 @ $3.57 | EDGAR |
| 2025-07-01 | 4 | Hayden Michael R — Director | Grant/award (A): 238,864 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Montalbano John S. — Director | Grant/award (A): 238,864 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Lo Andrew — Director | Grant/award (A): 238,864 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Thermopylae Holdings Ltd. — 10% owner | Purchase (P): 343,631 @ $2.16 | EDGAR |
| 2025-03-10 | 4 | Montalbano John S. — Director | Purchase (P): 25,000 @ $2.30 | EDGAR |
| 2025-03-07 | 4 | Montalbano John S. — Director | Purchase (P): 60,000 @ $2.34 | EDGAR |
| 2025-01-03 | 4 | Stimart Tryn — Chief Legal Officer | Grant/award (A): 832,033 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Lecault Veronique — Chief Operating Officer, Director | Grant/award (A): 832,033 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Booth Andrew — Chief Financial Officer | Grant/award (A): 1,352,054 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 2,730,109 (derivative) @ $0 | EDGAR |
| 2024-12-05 | 4 | Thermopylae Holdings Ltd. — 10% owner | Gift (G): 286,000 @ $0 | EDGAR |
| 2024-11-26 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Option exercise (M): 56,125 @ $2.70 · Option exercise (M): 56,125 (derivative) @ $0 | EDGAR |
| 2024-09-24 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Option exercise (M): 56,125 @ $2.70 · Option exercise (M): 56,125 (derivative) @ $0 | EDGAR |
| 2024-08-29 | 4 | Thermopylae Holdings Ltd. — 10% owner | Purchase (P): 283,516 @ $2.61 | EDGAR |
| 2024-06-24 | 4 | Lecault Veronique — Chief Operating Officer, Director | Option exercise (M): 83,334 @ $0.19 · Option exercise (M): 83,334 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Montalbano John S. — Director | Grant/award (A): 163,934 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Lo Andrew — Director | Grant/award (A): 163,934 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Hayden Michael R — Director | Grant/award (A): 163,934 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Option exercise (M): 56,125 @ $2.70 · Option exercise (M): 56,125 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Option exercise (M): 56,125 @ $2.70 · Option exercise (M): 56,125 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | Lecault Veronique — Chief Operating Officer, Director | Grant/award (A): 770,416 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | Stimart Tryn — Chief Legal Officer | Grant/award (A): 616,333 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | Booth Andrew — Chief Financial Officer | Grant/award (A): 770,416 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | Hansen Carl L. G. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 2,095,532 (derivative) @ $0 | EDGAR |
| 2023-12-19 | 4 | Thermopylae Holdings Ltd. — 10% owner | Gift (G): 210,000 @ $0 | EDGAR |
Recent 8-K events — AbCellera Biologics Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ABCL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →